US Index Futures are marginally lower in Tuesday’s premarket, awaiting important economic data, which...
Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations PR...
Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan PR...
Mallinckrodt plc Reports Second Quarter 2023 Financial Results and Reaffirms Full Year Guidance PR...
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal...
Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in...
Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal...
Mallinckrodt plc Reports First Quarter 2023 Financial Results and Reaffirms Full Year Guidance PR...
Mallinckrodt Recognized as Industry Innovator at National Organization for Rare Disorders (NORD) 2023 Rare...
The Buxton Helmsley Group, Inc. (together with certain of its affiliates, “BHG” or “we”), the New York City-based investment advisor to clients...
Mallinckrodt to Report Earnings Results for First Quarter 2023 PR Newswire DUBLIN, April 24, 2023 DUBLIN...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.